Use of high-field intraoperative magnetic resonance imaging to enhance the extent of resection of enhancing and nonenhancing gliomas

Neurosurgery

Volumn 74, Issue 4, 2014, Pages 339-348

  Mohammadi, Alireza Mohammad ^a   Sullivan, T Barrett ^a   Barnett, Gene H ^a   Recinos, Violette ^a   Angelov, Lilyana ^a   Kamian, Kambiz ^a   Vogelbaum, Michael A ^a,b  

^a NEUROLOGICAL INSTITUTE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Electrocorticography; Extent of resection; Glioblastoma; Low grade glioma; Residual tumor volume

Indexed keywords

STEROID;

ADULT; ANESTHESIA INDUCTION; ARTICLE; BASAL GANGLION; BRAIN EDEMA; CANCER LOCALIZATION; CANCER SURGERY; CAPSULA INTERNA; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CRANIOTOMY; DEEP VEIN THROMBOSIS; DIFFUSION TENSOR IMAGING; DRUG TREATMENT FAILURE; ELECTROCORTICOGRAPHY; EVOKED SOMATOSENSORY RESPONSE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FRONTAL LOBE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; GLIOBLASTOMA; GLIOMA; HEADACHE; HOSPITALIZATION; HUMAN; INSTITUTIONAL REVIEW; INTERVENTIONAL MAGNETIC RESONANCE IMAGING; INTRAOPERATIVE PERIOD; LANGUAGE DISABILITY; MAJOR CLINICAL STUDY; MALE; MENTAL DETERIORATION; MIDDLE AGED; MOTOR PERFORMANCE; NUCLEAR MAGNETIC RESONANCE SCANNER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OPERATION DURATION; PARIETAL LOBE; PATIENT HISTORY OF CHEMOTHERAPY; PATIENT HISTORY OF NEUROSURGERY; PATIENT HISTORY OF RADIOTHERAPY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEIZURE; TEMPORAL LOBE; TIME TO TREATMENT; TREATMENT DURATION; TUMOR VOLUME; VOLUMETRY; WEAKNESS; WORLD HEALTH ORGANIZATION; AGED; BRAIN NEOPLASMS; NEUROIMAGING; NEURONAVIGATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATIENT MONITORING; PROCEDURES; YOUNG ADULT;

ADULT; AGED; BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; NEUROIMAGING; NEURONAVIGATION; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84897449515     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0000000000000278     Document Type: Article

References (53)

1. Black P. Management of malignant glioma: role of surgery in relation to multimodality therapy. J Neurovirol. 1998;4(2):227-236.
2. Woodward DE, Cook J, Tracqui P, Cruywagen GC, Murray JD, Alvord EC Jr. A mathematical model of glioma growth. Cell Prolif. 1996;29(6):269-288.
3. Sanai N, Berger MS. Glioma extent of resection and its impact on patient outcome. Neurosurgery. 2008;62(4):753-766.
4. Claus EB, Horlacher A, Hsu L, et al. Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance. Cancer. 2005;103 (6):1227-1233.
5. Hardesty DA, Sanai N. The value of glioma extent of resection in the modern neurosurgical era. Front Neurol. 2012;3:140.
6. van Veelen ML, Avezaat CJ, Kros JM, van Putten W, Vecht C. Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery. J Neurol Neurosurg Psychiatry. 1998;64(5):581-587.
7. Smith JS, Chang EF, Lamborn KR, et al. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol. 2008;26(8):1338-1345.
8. McGirt MJ, Chaichana KL, Attenello FJ, et al. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery. 2008;63(4):700-707; author reply 707-708.
9. Karim AB, Maat B, Hatlevoll R, et al. A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys. 1996;36(3):549-556.
10. Knauth M, Wirtz CR, Tronnier VM, Aras N, Kunze S, Sartor K. Intraoperative MR imaging increases the extent of tumor resection in patients with high-grade gliomas. AJNR Am J Neuroradiol. 1999;20(9):1642-1646.
11. Keles GE, Chang EF, Lamborn KR, et al. Volumetric extent of resection and residual contrast enhancement on initial surgery as predictors of outcome in adult patients with hemispheric anaplastic astrocytoma. J Neurosurg. 2006;105(1):34-40.
12. Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS. An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg. 2011;115(1): 3-8.
13. Stummer W. Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery. 2008;62(3):564-576.
14. McGirt MJ, Chaichana KL, Gathinji M, et al. Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg. 2009;110(1):156-162.
15. Lacroix M, Abi-Said D, Fourney DR, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001;95(2):190-198.
16. Brown PD, Maurer MJ, Rummans TA, et al. A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. Neurosurgery. 2005;57(3):495-504.
17. Hammoud MA, Ligon BL, elSouki R, Shi WM, Schomer DF, Sawaya R. Use of intraoperative ultrasound for localizing tumors and determining the extent of resection: a comparative study with magnetic resonance imaging. J Neurosurg. 1996;84(5):737-741.
18. Engle DJ, Lunsford LD. Brain tumor resection guided by intraoperative computed tomography. J Neurooncol. 1987;4(4):361-370.
19. Barnett GH. The role of image-guided technology in the surgical planning and resection of gliomas. J Neurooncol. 1999;42(3):247-258.
20. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006;7 (5):392-401.
21. Schebesch KM, Proescholdt M, Höhne J, et al. Sodium fluorescein-guided resection under the YELLOW 560 nm surgical microscope filter in malignant brain tumor surgery-a feasibility study. Acta Neurochir(Wien). 2013;155(4):693-699.
22. Roessler K, Ungersboeck K, Aichholzer M, et al. Frameless stereotactic lesion contour-guided surgery using a computer-navigated microscope. Surg Neurol. 1998;49(3):282-288; discussion 288-289.
23. Lewin JS. Interventional MR imaging: concepts, systems, and applications in neuroradiology. AJNR Am J Neuroradiol. 1999;20(5):735-748.
24. Vogelbaum MA, Jost S, Aghi MK, et al. Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) working group. Neurosurgery. 2012;70(1):234-243; discussion 243-244.
25. Senft C, Bink A, Franz K, Vatter H, Gasser T, Seifert V. Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial. Lancet Oncol. 2011;12(11):997-1003.
26. Kubben PL, ter Meulen KJ, Schijns OE, ter Laak-Poort MP, van Overbeeke JJ, van Santbrink H. Intraoperative MRI-guided resection of glioblastoma multi-forme: a systematic review. The Lancet Oncol. 2011;12(11):1062-1070.
27. Lenaburg HJ, Inkabi KE, Vitaz TW. The use of intraoperative MRI for the treatment of glioblastoma multiforme. Technol Cancer Res Treat. 2009;8(2):159-162.
28. Schneider JP, Trantakis C, Rubach M, et al. Intraoperative MRI to guide the resection of primary supratentorial glioblastoma multiforme-a quantitative radiological analysis. Neuroradiology. 2005;47(7):489-500.
29. Nimsky C, Fujita A, Ganslandt O, Von Keller B, Fahlbusch R. Volumetric assessment of glioma removal by intraoperative high-field magnetic resonance imaging. Neurosurgery. 2004;55(2):358-370.
30. Bohinski RJ, Kokkino AK, Warnick RE, et al. Glioma resection in a shared-resource magnetic resonance operating room after optimal image-guided frameless stereotactic resection. Neurosurgery. 2001;48(4):731-742; discussion 742-744.
31. Wirtz CR, Knauth M, Staubert A, et al. Clinical evaluation and follow-up results for intraoperative magnetic resonance imaging in neurosurgery. Neurosurgery. 2000;46(5):1112-1120; discussion 1120-1122.
32. Hatiboglu MA, Weinberg JS, Suki D, et al. Impact of intraoperative high-field magnetic resonance imaging guidance on glioma surgery: a prospective volumetric analysis. Neurosurgery. 2009;64(6):1073-1081; discussion 1081.
33. Kuhnt D, Ganslandt O, Schlaffer SM, Buchfelder M, Nimsky C. Quantification of glioma removal by intraoperative high-field magnetic resonance imaging: an update. Neurosurgery. 2011;69(4):852-862; discussion 862-863.
34. Pamir MN, Ozduman K, Dinçer A, Yildiz E, Peker S, Ozek MM. First intraoperative, shared-resource, ultrahigh-field 3-Tesla magnetic resonance imaging system and its application in low-grade glioma resection. J Neurosurg. 2010;112(1):57-69.
35. Pamir MN, Özduman K, Yildiz E, Sav A, Dinçer A. Intraoperative magnetic resonance spectroscopy for identification of residual tumor during low-grade glioma surgery. J Neurosurg. 2013;118(6):1191-1198.
36. Keles GE, Anderson B, Berger MS. The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere. Surg Neurol. 1999;52(4):371-379.
37. Pope WB, Sayre J, Perlina A, Villablanca JP, Mischel PS, Cloughesy TF. MR imaging correlates of survival in patients with high-grade gliomas. AJNR Am J Neuroradiol. 2005;26(10):2466-2474.
38. Orringer D, Lau D, Khatri S, et al. Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival. J Neurosurg. 2012; 117(5):851-859.
39. Bloch O, Han SJ, Cha S, et al. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article. J Neurosurg. 2012;117 (6):1032-1038.
40. Senft C, Franz K, Blasel S, et al. Influence of iMRI-guidance on the extent of resection and survival of patients with glioblastoma multiforme. Technol Cancer Res Treat. 2010;9(4):339-346.
41. Dea N, Fournier-Gosselin MP, Mathieu D, Goffaux P, Fortin D. Does extent of resection impact survival in patients bearing glioblastoma? Can J Neurol Sci. 2012; 39(5):632-637.
42. Philippon JH, Clemenceau SH, Fauchon FH, Foncin JF. Supratentorial low-grade astrocytomas in adults. Neurosurgery. 1993;32(4):554-559.
43. Scerrati M, Roselli R, Iacoangeli M, Pompucci A, Rossi GF. Prognostic factors in low grade (WHO grade II) gliomas of the cerebral hemispheres: the role of surgery. J Neurol Neurosurg Psychiatry. 1996;61(3):291-296.
44. Nicolato A, Gerosa MA, Fina P, Iuzzolino P, Giorgiutti F, Bricolo A. Prognostic factors in low-grade supratentorial astrocytomas: a uni-multivariate statistical analysis in 76 surgically treated adult patients. Surg Neurol. 1995;44(3):208-221; discussion 221-223.
45. Ito S, Chandler KL, Prados MD, et al. Proliferative potential and prognostic evaluation of low-grade astrocytomas. J Neurooncol. 1994;19(1):1-9.
46. Keles GE, Lamborn KR, Berger MS. Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. J Neurosurg. 2001;95(5):735-745.
47. Ius T, Isola M, Budai R, et al. Low-grade glioma surgery in eloquent areas: volumetric analysis of extent of resection and its impact on overall survival. A single-institution experience in 190 patients: clinical article. J Neurosurg. 2012;117(6):1039-1052.
48. Kuhnt D, Becker A, Ganslandt O, Bauer M, Buchfelder M, Nimsky C. Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance. Neuro Oncol. 2011;13(12):1339-1348.
49. Sanai N, Berger MS. Recent surgical management of gliomas. Adv Exp Med Biol. 2012;746:12-25.
50. Stummer W, Tonn JC, Mehdorn HM, et al. Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article. J Neurosurg. 2011;114(3):613-623.
51. Berger MS, Rostomily RC. Low grade gliomas: functional mapping resection strategies, extent of resection, and outcome. J Neurooncol. 1997;34(1):85-101.
52. Basser PJ, Pajevic S, Pierpaoli C, Duda J, Aldroubi A. In vivo fiber tractography using DT-MRI data. Magn Reson Med. 2000;44(4):625-632.
53. Senft C, Forster MT, Bink A, et al. Optimizing the extent of resection in eloquently located gliomas by combining intraoperative MRI guidance with intraoperative neurophysiological monitoring. J Neurooncol. 2012;109(1):81-90.